SCHEMBL9610690

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL144518	0.89	CREBBP (0.54)	CREBBPKDM4EGLAGAACA12
	SCHEMBL30613110	0.88	NOS3 (0.54)	CREBBPKDM4EGLAGAACA12
	SCHEMBL29114117	0.88	NOS3 (0.54)	CREBBPKDM4EGLAGAACA12
	SCHEMBL9610679	0.85	CREBBP (0.51)	CREBBPKDM4EGLAGAACA12
	SCHEMBL14563058	0.85	CREBBP (0.61)	CREBBPKDM4EPOLBTDP1NOS1
	SCHEMBL28723832	0.84	CREBBP (0.52)	CREBBPKDM4EPOLBTDP1NOS1
	SCHEMBL18785888	0.84	CREBBP (0.52)	CREBBPKDM4EPOLBTDP1NOS1
	SCHEMBL15395817	0.83	NOS1 (0.56)	CREBBPKDM4EGAAPOLBTDP1
	SCHEMBL17717880	0.81	CREBBP (0.50)	CREBBPKDM4EPOLBTDP1NOS1
	SCHEMBL9610676	0.81	CREBBP (0.56)	CREBBPKDM4EGLAGAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.